SCHEMBL2117794

SCHEMBL2117794

COc1cc(S(=O)(=O)Nc2cc(C)cc(-c3nnco3)c2)sc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
GAA P10253 1/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39
PSENEN Q9NZ42 1/20 0.39
LMNA P02545 3/20 0.37
TP53 P04637 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TSHR P16473 1/20 0.35
NOTUM Q6P988 2/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2117139 0.80 TP53 (0.46) MAPTALDH1A1HPGDGAACYP3A4
SCHEMBL2118085 0.77 HPGD (0.55) ALDH1A1HPGDMAPK1GAACYP3A4
SCHEMBL2116820 0.73 GAA (0.47) MAPTALDH1A1HPGDGAACYP3A4
SCHEMBL2119637 0.73 GAA (0.49) MAPTALDH1A1HPGDMAPK1GAA
SCHEMBL2117286 0.72 SYK (0.48) MAPTHPGDGAACYP3A4CYP2D6
SCHEMBL2118117 0.70 SLC22A12 (0.36) LMNAMEN1KMT2ATHRBSMN1; SMN2
SCHEMBL2119867 0.70 GAA (0.48) MAPTALDH1A1HPGDMAPK1GAA
SCHEMBL2119710 0.69 GAA (0.43) MAPTALDH1A1HPGDGAACYP3A4
SCHEMBL2119912 0.68 GAA (0.47) MAPTHPGDMAPK1GAACYP3A4
SCHEMBL16982635 0.67 NOTUM (0.64) MAPTALDH1A1HPGDMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095012-A1 TOLUIDINE SULFONAMIDES AND THEIR USE ELARA PHARMACEUTICALS GMBH (DE) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095012-A1 TOLUIDINE SULFONAMIDES AND THEIR USE HIF1A, HIF1AN, EGLN3 MAPT 4747/4885ALDH1A1 1063/4885HPGD 1027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.